Delivery Order SPE2DB24D2216-SPE2DB25FGPHJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,101.78 to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units, with a contract ceiling value of $1,811.34. This competitively awarded, firm fixed-price delivery order is not subject to any small business set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 11,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Belsomra 20 mg tablets (30-count) at a ceiling value of $1,088.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is classified as a child contract, meaning it derives from a larger indefinite delivery vehicle. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Belsomra 20 mg tablets (30-count units) valued at $1,706.39. This firm fixed-price delivery order, which carries an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply agreement extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Belsomra 20 mg tablets (30-count packages) valued at $1,833.31. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 17, 2025, for the supply of Belsomra 10 mg tablets (30-count packaging). This contract, valued at $1,078.38, is classified as a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. The award was made without a set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp will perform...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30-count) under a firm fixed-price contract type. The award, made on September 19, 2025, carries a ceiling value of $1,524.46 and is scheduled for completion by September 22, 2025. This competitively awarded delivery order contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belsomra 10 mg tablets in a quantity of 30 units, with a ceiling value of $4,278.69. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The contract is set for ultimate completion on September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,427.58 to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract was awarded competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Belsomra is a prescription medication used for sleep disorders, reflecting the pharmaceutical...
- This delivery order, awarded June 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Belsomra 20 mg tablets (30-count units) with a ceiling value of $1,058.07. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPHJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates substantial capability in delivering diverse pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms with firm fixed pricing across varying order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |